Timothy G. Youngquist 2020 Irrevocable Trust’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.2M	Buy	+34,341	New	+$1.78M	0.43%	34

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Timothy G. Youngquist 2020 Irrevocable Trust's KNSA Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 34,341 shares worth $2.2M. The stake represents 0.43% of the portfolio and ranks #34 among its holdings.

266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Timothy G. Youngquist 2020 Irrevocable Trust held 34,341 shares of Kiniksa Pharmaceuticals worth $2.2M as of Q2 2026.
Kiniksa Pharmaceuticals was a new Timothy G. Youngquist 2020 Irrevocable Trust position in Q2 2026.
Kiniksa Pharmaceuticals made up 0.43% of Timothy G. Youngquist 2020 Irrevocable Trust's portfolio in Q2 2026, its #34 holding.
266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.